Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.93 - $2.35 $67,890 - $171,552
73,001 New
73,001 $153,000
Q2 2022

Aug 15, 2022

SELL
$3.27 - $8.76 $62,270 - $166,816
-19,043 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$7.56 - $14.3 $143,965 - $272,314
19,043 New
19,043 $156,000
Q3 2021

Nov 15, 2021

SELL
$16.69 - $26.05 $211,345 - $329,871
-12,663 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$18.15 - $27.75 $229,833 - $351,398
12,663 New
12,663 $321,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $159M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Quadrature Capital LTD Portfolio

Follow Quadrature Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quadrature Capital LTD with notifications on news.